Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > PUBCO and RS split at 10-1?
View:
Post by Bigmac4000 on Jun 20, 2023 10:46am

PUBCO and RS split at 10-1?

How did i miss this notice,  FSD is doing a 10/1 RS? Did I read that correctly? The the spin off shares are handed to us losers? I got curious and started looking up PUBCO and saw this release. It caught my eye when I saw this information 
"Founded: 1994
Headquarters: Cobourg, Canada
Number of employees: 17 (2022)
Subsidiaries: Prismic Pharmaceuticals, Inc.Pubco2861435 Ontario Inc.FV Pharma Inc
the stumbled across the below post and the last paragraph . 
"
 
 

FSD Pharma Inc. agreed to Spin-Off Pubco.

 
04/12/2023 EDT
share with twitter
share with LinkedIn
share with facebook
 
 
 

FSD Pharma Inc. (CNSX:HUGE) agreed to Spin-Off Pubco on April 12, 2023. Pubco will be separated into an independent public company, all shareholders of the Company will exchange their shares in the capital of the Company, for the same number of existing shares of the Company and common shares in the capital of the Pubco on a pro rata basis. Following the Spin-out Transaction, FSD Pharma will remain listed on the NASDAQ Stock Market and Canadian Securities Exchange.

The completion of the Spin-out Transaction is subject to shareholders, court regulatory and the satisfaction of customary closing conditions. FSD Pharma will hold an annual general and special shareholders meeting on June 29, 2023, where Shareholders will be able vote on the Spin-out Transaction. As of May 12, 2023, For Spin-Out transaction the necessary documentation for shareholder approval will not be ready in time for mailing deadline for the June 29, 2023, therefore, the shareholders meeting on June 29, 2023 will proceed as a general annual meeting of FSD Pharma shareholders and the company will schedule a separate special meeting to approve the Spin-Out in the future.

The record date for shareholders entitled to vote at the Meeting will be May 15, 2023. Transaction is expected to be completed in July 2023. As of May 31, 2023, the Board approved the Reverse Stock Split at a reverse stock split ratio of 1-for-10." 

Comment by breakout on Jun 20, 2023 12:30pm
Maybe you will be nicer to the ones holding your money from now on
Comment by Bigmac4000 on Jun 20, 2023 1:35pm
And again, I have no idea what you are talking about. Clearly you missed the part where i was looking for clarification on some technical details and you rambled lol. Now let the adults talk please. 
Comment by Walter333 on Jun 20, 2023 3:04pm
If the lawsuit against them has some teeth and the judgement goes GBB's way SP will most likely crater and an RS would most likely be implemented in order to keep money flowing the insiders way. Since there is a class A class B shareholder structure, with insiders controlling the majority interest of voting shares, there is nothing to stop them from continuing their track record of this type ...more